Device Devices

Hillrom - Centrella Smart+ Bed

Payments companies reported to CMS as associated with Hillrom - Centrella Smart+ Bed. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$23Kassociated payments (2023-2025)
58clinicians with associated payments
1company reporting

By year

2023 $2,293
2024 $9,626
2025 $11K

Payments reported as associated with Hillrom - Centrella Smart+ Bed, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Family $4,682
Nurse Practitioner $2,410
Adult Health (Clinical Nurse Specialist) $2,251
Acute Care (Clinical Nurse Specialist) $1,800
Acute Care (Nurse Practitioner) $1,388
Physician Assistant $1,362

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Hillrom - Centrella Smart+ Bed

These are the largest totals companies reported as associated with Hillrom - Centrella Smart+ Bed. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Laura Swoboda Menomonee Falls, WI Family $3,780.00
Jill Cox Englewood, NJ Adult Health (Clinical Nurse Specialist) $2,000.60
Donna Bond Roanoke, VA Acute Care (Clinical Nurse Specialist) $1,800.00
Jenny Niblock Colby, KS Nurse Practitioner $1,770.59
Christina Hull East Setauket, NY Physician Assistant $1,361.95
Richard Rodriguez San Antonio, TX Ophthalmology $1,298.97
Monique Lambert Highland Park, IL Acute Care (Nurse Practitioner) $1,255.11
David Wong Houston, TX Emergency Medicine $1,244.84
Christine Ralyea Columbia, SC $1,187.91
Julie Ross Charleston, SC Neonatal-Perinatal Medicine $973.28

Prescribed Hillrom - Centrella Smart+ Bed?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.